Pharma firm Glenmark today said that it has received the approval of US health regulator USFDA to introduce generic theophylline tablets, used for treating asthma and other lung diseases, in the American nation.

Glenmark Generics Inc (GGI), the subsidiary of Glenmark Generics Ltd, will start marketing and distributing the medicine, in 400mg and 600 mg strengths, with immediate effect.

Also Read   Related Stories News Now - Parabolic Drugs gets EU nod for its facility - Orchid Chem gets US tentative nod for generic drug - Glenmark gets approval to launch acne gel in the US - After pvt banks, FIIs may focus on other sectors - Sun Pharma gets FDA nod for Optivar generic - Sun Pharma receives USFDA nod for anti-anxiety drug

Also Read   Related Stories News Now - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report More

The market for theophylline tablets is estimated to be USD 8 million per annum and GGI expects a "successful launch, based on limited competition existing in this niche segment".

Theophylline extended-release tablets are indicated for treatment of symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases such as emphysema and chronic bronchitis.

After this approval, Glenmark's current portfolio has increased to 56 generic drugs for distribution in the US. It also has over 50 pending ANDAs filed with the USFDA for approvals.

"In addition to these internal filings, GGI continues to identify and explore external development partnerships to supplement the growth of the existing pipeline and portfolio," the statement said.

The shares of Glenmark Pharmaceuticals were trading flat at Rs 278.50 on the Bombay Stock Exchange this afternoon.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report

Tags : Glenmark | USFDA | pharma | nod   Read Business news in  Advertisements -  Journey on, We are by Your Side. Click here to know more -  2 Lac Apartments, 1 Lac House / Plots. Click here -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  The Best Seller is Also the No. 1 in Mileage. Click here -  Watch The Film Here. Click here to know more.. -  Leader in Passenger Car & Automobile Tyres. Click here -  1 billion in saving for Unilever without any tangles. -  A Brand New Server at a Price That Fits Your Budget. Click here -  Learn How One City is Running on FOOD SCRAPS. -  One Partnership Endless Possibilities. Click here to know more -  Helping doctors detect diseases earlier, saving costs & extending lives. -  36 Lakhs can get you a pool of Luxuries. Click here -  Which is the best plan for your daughter -  Check out the TRUE COLOURS of your Stocks, Now for FREE! -  One of the leading business schools in the world.Know More